MedTrace Logo

Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery

NCT05730413 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2023-07-28

No results posted yet for this study

Summary

The goal of this interventional clinical trial is compare between two different dose regimens of bisoprolol (beta-blocker) in CABG patients in terms of efficacy and safety.

Conditions

Interventions

DRUG

Bisoprolol

Bisoprolol dose was divided to be taken as 2.5 mg twice per day from hospital admission to discharge.

DRUG

Bisoprolol

Bisoprolol was taken as 5 mg per day from hospital admission till discharge.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Reem Ihab, Bsc · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-25
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05730413 on ClinicalTrials.gov